Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AXSM Axsome Therapeutics, Inc.

交易中 05-07 14:40:59 EDT

75.64

-0.30

-0.40%

最高75.95	最低73.52	成交量28.92万
今开75.58	昨收75.94	日振幅3.20%
总市值35.92亿	流通市值26.47亿	总股本4,749万
成交额2,170万	换手率0.83%	流通股本3,500万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics, Inc.","latestPrice":75.64,"timestamp":1715107246874,"preClose":75.94,"halted":0,"volume":289156,"delay":0,"floatShares":34996127,"shares":47493320,"eps":-5.269999,"marketStatus":"交易中","marketStatusCode":2,"change":-0.3,"latestTime":"05-07 14:40:59 EDT","open":75.58,"high":75.95,"low":73.52,"amount":21696502.3884,"amplitude":0.031999,"askPrice":75.75,"askSize":41,"bidPrice":75.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.269999,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715112000000},"adr":0,"listingDate":1447909200000,"adjPreClose":75.94,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":75.97,"preClose":75.94,"latestTime":"09:28 EDT","volume":239,"amount":18180.76346,"timestamp":1715088481042},"postHourTrading":{"tag":"盘后","latestPrice":75.94,"preClose":75.94,"latestTime":"19:40 EDT","volume":142554,"amount":10825469.43,"timestamp":1715038822883},"volumeRatio":0.604019},"requestUrl":"/m/hq/s/AXSM/","defaultTab":"news","newsList":[{"id":"2433853733","title":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433853733","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433853733?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:24","pubTimestamp":1715102694,"startTime":"0","endTime":"0","summary":"花旗：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由127.00美元调整至125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801245687dd2aed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432907276","title":"Axsome Therapeutics Inc    预计每股亏损 1.20 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432907276","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432907276?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:48","pubTimestamp":1714751294,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc    将于5月6日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，14位分析师的平均预期显示，这家总部位于纽约的公司的营收预计将从去年同期的9458万美元下降22.5%，至7329.5万美元。* LSEG分析师对Axsome Therapeutics Inc的平均预期为每股亏损1.20美元。* 华尔街对Axsome Therapeutics Inc的12个月目标价中位数为115.00美元，高于其最新收盘价74.19美元。5月3日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431865675","title":"Axsome Therapeutics, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865675","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431865675?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:35","pubTimestamp":1714397720,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时35分，Axsome Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。该信息摘要如下：大摩：上调Axsome Therapeutics评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292135207a572873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292135207a572873&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431887199","title":"大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431887199","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431887199?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:35","pubTimestamp":1714383352,"startTime":"0","endTime":"0","summary":"大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042917355687be9471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042917355687be9471&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429908582","title":"Axsome Therapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报71.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429908582","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429908582?lang=zh_cn&edition=full","pubTime":"2024-04-23 02:37","pubTimestamp":1713811054,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日02时37分，Axsome Therapeutics, Inc.股票出现异动，股价大幅拉升5.01%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.12%。其相关个股中，Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大，Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃，换手率分别为199.72%、129.94%、95.72%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.，振幅分别为252.97%、82.14%、68.75%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230237357a549e8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230237357a549e8f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428468665","title":"Axsome Therapeutics, Inc.盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428468665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428468665?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:45","pubTimestamp":1713465906,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时45分，Axsome Therapeutics, Inc.股票出现异动，股价急速下挫5.01%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为10640.66%、112.15%、50.63%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为126.85%、75.31%、73.93%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190245067a53d1b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190245067a53d1b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426497473","title":"坎托菲茨杰拉德公司：重申Axsome Therapeutics(AXSM.US)评级，由增持调整至增持评级, 目标价107.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426497473","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426497473?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:45","pubTimestamp":1712756738,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Axsome Therapeutics(AXSM.US)评级，由增持调整至增持评级, 目标价107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145428761799a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145428761799a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422947535","title":"Axsome Therapeutics睡眠障碍疗法在后期试验中获得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2422947535","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422947535?lang=zh_cn&edition=full","pubTime":"2024-03-25 18:36","pubTimestamp":1711362981,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月25日 - Axsome Therapeutics   周一表示，其治疗睡眠障碍的疗法达到了一项后期研究的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420752182","title":"Axsome Therapeutics, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420752182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420752182?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:43","pubTimestamp":1710859381,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时43分，Axsome Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为800.08%、394.76%、135.76%，振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.，振幅分别为50.91%、49.87%、47.94%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192243017a4db691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192243017a4db691&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420255290","title":"美国研究综述-美国大厦、莱纳尔、耐克","url":"https://stock-news.laohu8.com/highlight/detail?id=2420255290","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420255290?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:17","pubTimestamp":1710832652,"startTime":"0","endTime":"0","summary":"    路透社3月19日 - 华尔街证券分析师周二调整了对美国塔、莱纳尔和耐克等几家美国上市公司的评级和目标价。* 耐克公司   ：Wedbush将目标价从131美元下调至115美元 * Zoom Video Communications   ：杰富瑞给予该公司 \"持有 \"评级，目标价为70美元 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419818808","title":"Axsome Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419818808","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419818808?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:32","pubTimestamp":1710523967,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时32分，Axsome Therapeutics, Inc.股票出现异动，股价快速拉升5.02%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为333.01%、79.56%、30.99%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Outlook Therapeutics, Inc.，振幅分别为114.29%、63.00%、49.39%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160132477a4d1a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160132477a4d1a72&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418658396","title":"Axsome Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418658396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418658396?lang=zh_cn&edition=full","pubTime":"2024-03-12 01:33","pubTimestamp":1710178415,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日01时33分，Axsome Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Cingulate Inc C/Wts 10/12/2026 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Transcode Therapeutics, Inc.较为活跃，换手率分别为5358.05%、193.35%、109.08%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为152.82%、145.83%、83.63%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240312013335861dd232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240312013335861dd232&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418606203","title":"Axsome Therapeutics, Inc.盘中异动 大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418606203","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418606203?lang=zh_cn&edition=full","pubTime":"2024-03-09 01:15","pubTimestamp":1709918141,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日01时15分，Axsome Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Scisparc Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为981.39%、242.13%、222.32%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为191.50%、162.20%、68.22%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240309011542861dcade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240309011542861dcade&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417244103","title":"Axsome Therapeutics, Inc.盘中异动 快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417244103","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417244103?lang=zh_cn&edition=full","pubTime":"2024-03-07 03:54","pubTimestamp":1709754845,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日03时54分，Axsome Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，知临集团、Nkgen Biotech Inc C/Wts 31/05/2028、Biomx Inc.涨幅较大，知临集团、Nkgen Biotech, Inc.、Biomx Inc.较为活跃，换手率分别为1483.39%、464.21%、291.39%，振幅较大的相关个股有知临集团、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为1024.76%、336.43%、255.70%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307035405861dbe27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307035405861dbe27&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417178155","title":"Axsome Therapeutics, Inc.盘中异动 下午盘大幅跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417178155","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417178155?lang=zh_cn&edition=full","pubTime":"2024-03-05 02:27","pubTimestamp":1709576849,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日02时27分，Axsome Therapeutics, Inc.股票出现异动，股价快速下挫5.13%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为2459.70%、551.26%、175.52%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Quoin Pharmaceuticals Ltd、Ocean Biomedical, Inc.，振幅分别为149.44%、103.97%、88.50%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305022730791722a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305022730791722a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413437097","title":"Axsome Therapeutics Inc2023财年实现净利润-2.39亿美元，同比减少27.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413437097","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413437097?lang=zh_cn&edition=full","pubTime":"2024-02-21 07:26","pubTimestamp":1708471617,"startTime":"0","endTime":"0","summary":"12月31日，Axsome Therapeutics Inc公布财报，公告显示公司2023财年净利润为-2.39亿美元，同比减少27.81%；其中营业收入为2.71亿美元，同比增加441.57%，每股基本收益为-5.27美元。机构评级：截至2023年12月31日，当前有14家机构对Axsome Therapeutics Inc目标价做出预测，其中目标均价为123.00美元，其中最低目标价为96.00美元，最高目标价为180.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022107270181a145ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022107270181a145ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412105476","title":"Axsome Therapeutics Inc盘中异动 早盘急速下跌9.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412105476","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412105476?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439545,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Axsome Therapeutics Inc股票出现异动，股价大幅下跌9.14%。截至发稿，该股报84.32美元/股，成交量10.1817万股，换手率0.22%，振幅3.23%。Axsome Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Monopar Therapeutics Inc、Scisparc Ltd、Dermata Therapeutics Inc C/Wts 13/08/2026 涨幅较大，Scisparc Ltd、Clearmind Medicine Inc、Monopar Therapeutics Inc较为活跃，换手率分别为1564.77%、277.75%、214.57%，振幅较大的相关个股有Monopar Therapeutics Inc、Scisparc Ltd、Better Therapeutics Inc，振幅分别为43.78%、27.30%、17.62%。Axsome Therapeutics Inc公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022322587a57d12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022322587a57d12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412086311","title":"Axsome Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2412086311","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412086311?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:31","pubTimestamp":1708439500,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc   报告，截至12月底的季度调整后每股亏损2.08美元，低于去年同期的每股收益1.41美元。14位分析师对该季度的平均预期是每股亏损1.17美元。华尔街预期为每股亏损 1.36 美元至 1.07 美元。* 营收同比增长 193.5%，达到 7153 万美元；分析师预期为 6756 万美元。* Axsome Therapeutics 公司公布的本季度每股收益为亏损 2.08 美元。* 该公司一季度亏损 9865 万美元。* Axsome Therapeutics Inc 的股价本季度上涨了 16.6%。华尔街对 Axsome Therapeutics Inc 的 12 个月目标价中位数为 112.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411663168","title":"Axsome Therapeutics Inc    预计每股亏损 1.17 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411663168","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411663168?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:08","pubTimestamp":1708092502,"startTime":"0","endTime":"0","summary":"   * Axsome Therapeutics Inc    将于2月20日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于纽约的公司的营收有望从去年同期的2437万美元增长177.2%，达到6756.4万美元。* LSEG分析师对Axsome Therapeutics Inc的平均预期为每股亏损1.17美元。* 华尔街对 Axsome Therapeutics Inc 的 12 个月目标价中位数为 112.50 美元，高于其 93.46 美元的最新收盘价。2月16日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.axsome.com","stockEarnings":[{"period":"1week","weight":0.0305},{"period":"1month","weight":0.0511},{"period":"3month","weight":-0.199},{"period":"6month","weight":0.2336},{"period":"1year","weight":0.0298},{"period":"ytd","weight":-0.0459}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Axsome Therapeutics, Inc.成立于2012年1月。该公司是一家临床阶段的生物制药企业，开发新的治疗疼痛和其他中枢神经系统或中枢神经系统，疾病管理。通过专注于这一治疗领域，他们正在解决显著和不断增长的市场，其中目前的治疗选择是有限或不充分的。他们的目标是成为一个完全集成的生物制药公司开发和商业化的拓展提供给医护人员的治疗方案，提高生活疼痛和其他中枢神经系统疾病患者的生命分化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.061264},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.054934},{"month":3,"riseRate":0.333333,"avgChangeRate":0.073863},{"month":4,"riseRate":0.777778,"avgChangeRate":0.172294},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.048056},{"month":6,"riseRate":0.625,"avgChangeRate":0.143979},{"month":7,"riseRate":0.5,"avgChangeRate":-0.044552},{"month":8,"riseRate":0.5,"avgChangeRate":0.039182},{"month":9,"riseRate":0.375,"avgChangeRate":-0.026043},{"month":10,"riseRate":0.5,"avgChangeRate":0.002414},{"month":11,"riseRate":0.625,"avgChangeRate":0.164861},{"month":12,"riseRate":0.777778,"avgChangeRate":0.225168}],"exchange":"NASDAQ","name":"Axsome Therapeutics, Inc.","nameEN":"Axsome Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Axsome Therapeutics, Inc.,AXSM,Axsome Therapeutics, Inc.股票,Axsome Therapeutics, Inc.股票老虎,Axsome Therapeutics, Inc.股票老虎国际,Axsome Therapeutics, Inc.行情,Axsome Therapeutics, Inc.股票行情,Axsome Therapeutics, Inc.股价,Axsome Therapeutics, Inc.股市,Axsome Therapeutics, Inc.股票价格,Axsome Therapeutics, Inc.股票交易,Axsome Therapeutics, Inc.股票购买,Axsome Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}